跳至主要内容
临床试验/IRCT20240305061171N1
IRCT20240305061171N1已完成3 期

Comparing the effects of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients undergoing infertility treatment.

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Polycystic ovary syndrome according to Rotterdam criteria
  • Age 18 to 40 years
  • The number of antral follicles (AFC) above 20
  • Anti-Müllerian hormone (AMH) more than 3.36 ng/ml
  • Body mass index (BMI) less than 30 kg/m2

排除标准

  • Suffering from endometriosis
  • Decreased ovarian reserve
  • Chromosomal abnormalities
  • History of sensitivity to drugs that inhibit dopamine or cabergoline
  • Patients who do not take the desired drugs on a daily basis

研究者

相似试验